Zhiyuan Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhiyuan Zhang has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
Xiuli Zhang
Oral Bioengineering Lab, Shanghai Research Institute of Stomatology, Ninth People's Hospital Affiliated to Shanghai Jiao Tong University, School of Medicine, Shanghai 200011, China
8 shared publicationsJun Zhao
Department of Orthodontics, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology, National Clinical Research Center of Stomatology, Shanghai, China
6 shared publicationsShaoyi Wang
Department of Oral Surgery, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology, National Clinical Research Center of Stomatology, Shanghai, China
6 shared publicationsXinquan Jiang
Department of Prosthodontics, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology, National Clinical Research Center of Stomatology, Shanghai, China
6 shared publications- Ping Zhang
Department of Oral and Maxillofacial Surgery, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China
5 shared publications - Qin Xu
Department of Oral Maxillofacial & Head and Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
5 shared publications
Latest Publications
- 30 April 2018
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 78 (9) , 2262-2276
Proteolytic Release of the p75NTR Intracellular Domain by ADAM10 Promotes Metastasis and Resistance to Anoikis
Resistance to anoikis allows cancer cells to survive during systemic circulation; however, the mechanism underlying anoikis resistance remains unclear. Here we show that A disintegrin and metalloprotease 10 (ADAM10)–mediated cleavage of p75 neurotrophin receptor (p75NTR) and subsequent generation of the p75NTR intracellular domain (ICD) endow cancer cells with resistance to anoikis. p75NTR ICD promoted expression of TNF receptor–associated factor 6 (TRAF6), a critical intermediary in p75NTR ICD–mediated signal transduction, at the translational level. Cell detachment–induced activation of EGFR triggered autoubiquitination of TRAF6 by facilitating its dimerization, subsequently activated NFκB, and eventually led to anoikis resistance. ADAM10 and p75NTR ICD also promoted tumor metastasis formation in vivo. Together, our findings uncover a previously unknown function for the ADAM10-p75NTR ICD-TRAF6-NFκB axis in preventing anoikis and suggest ADAM10 and p75NTR ICD as potential cancer therapeutic targets. Significance: These findings identify the ADAM10-p75NTR ICD-TRAF6-NFκB signaling axis as a potential candidate for cancer therapy. Cancer Res; 78(9); 2262–76. ©2018 AACR.
- 30 April 2018
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 78 (9) , 2262-2276
Proteolytic Release of the p75NTR Intracellular Domain by ADAM10 Promotes Metastasis and Resistance to Anoikis
Resistance to anoikis allows cancer cells to survive during systemic circulation; however, the mechanism underlying anoikis resistance remains unclear. Here we show that A disintegrin and metalloprotease 10 (ADAM10)–mediated cleavage of p75 neurotrophin receptor (p75NTR) and subsequent generation of the p75NTR intracellular domain (ICD) endow cancer cells with resistance to anoikis. p75NTR ICD promoted expression of TNF receptor–associated factor 6 (TRAF6), a critical intermediary in p75NTR ICD–mediated signal transduction, at the translational level. Cell detachment–induced activation of EGFR triggered autoubiquitination of TRAF6 by facilitating its dimerization, subsequently activated NFκB, and eventually led to anoikis resistance. ADAM10 and p75NTR ICD also promoted tumor metastasis formation in vivo. Together, our findings uncover a previously unknown function for the ADAM10-p75NTR ICD-TRAF6-NFκB axis in preventing anoikis and suggest ADAM10 and p75NTR ICD as potential cancer therapeutic targets. Significance: These findings identify the ADAM10-p75NTR ICD-TRAF6-NFκB signaling axis as a potential candidate for cancer therapy. Cancer Res; 78(9); 2262–76. ©2018 AACR.
- Open Access
- 22 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-12
Growth differentiation factor 15 promotes blood vessel growth by stimulating cell cycle progression in repair of critical-sized calvarial defect
Repair of large bone defects remains a challenge for surgeons, tissue engineering represents a promising approach. However, the use of this technique is limited by delayed vascularization in central regions of the scaffold. Growth differentiation factor 15(GDF15) has recently been reported to be a potential angiogenic cytokine and has an ability to promote the proliferation of human umbilical vein endothelial cells(HUVECs). Whether it can be applied for promoting vascularized bone regeneration is still unknown. In this study, we demonstrated that GDF15 augmented the expression of cyclins D1 and E, induced Rb phosphorylation and E2F-1 nuclear translocation, as well as increased HUVECs proliferation. Furthermore, we also observed that GDF15 promoted the formation of functional vessels at an artificially-induced angiogenic site, and remarkably improved the healing in the repair of critical-sized calvarial defects. Our results confirm the essential role of GDF15 in angiogenesis and suggest its potential beneficial use in regenerative medicine.
- 22 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-12
Open AccessGrowth differentiation factor 15 promotes blood vessel growth by stimulating cell cycle progression in repair of critical-sized calvarial defect
Repair of large bone defects remains a challenge for surgeons, tissue engineering represents a promising approach. However, the use of this technique is limited by delayed vascularization in central regions of the scaffold. Growth differentiation factor 15(GDF15) has recently been reported to be a potential angiogenic cytokine and has an ability to promote the proliferation of human umbilical vein endothelial cells(HUVECs). Whether it can be applied for promoting vascularized bone regeneration is still unknown. In this study, we demonstrated that GDF15 augmented the expression of cyclins D1 and E, induced Rb phosphorylation and E2F-1 nuclear translocation, as well as increased HUVECs proliferation. Furthermore, we also observed that GDF15 promoted the formation of functional vessels at an artificially-induced angiogenic site, and remarkably improved the healing in the repair of critical-sized calvarial defects. Our results confirm the essential role of GDF15 in angiogenesis and suggest its potential beneficial use in regenerative medicine.
- Open Access
- 27 July 2015
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (28) , 25660-25676
Disruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK
Disruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK
- 27 July 2015
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (28) , 25660-25676
Open AccessDisruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK
Disruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK
- Open Access
- 4 November 2014
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 108 (6) , 473-480
Pulsed dye laser therapy for infantile hemangiomas: a systemic review and meta-analysis
Background: Infantile hemangiomas (IH) are common pediatric tumors. This meta-analysis was performed to review the therapeutic efficacy and safety of pulsed dye laser (PDL) in the treatment of IH. Methods: Seven databases were searched, including PubMed, OvidSP, Karger, Elsevier, EMBASE, Web of Science and Wiley Online Library. The review collected the characteristics of year of publication, hemangiomas cases, prior treatment, laser parameters, adverse side, pretreatment symptom, and number of response from all articles. Results: A total of 1580 studies were identified, the first round search retrieved 39 articles met inclusion criteria. Of those, only 13 articles with 1529 hemangiomas were included in the meta-analysis. This meta-analysis demonstrated an overall resolution rate of 89.1% with 6.28% incidence of adverse effect. Conclusion: PDL may be the effective modality to decrease the proliferative phase and accelerate rates of involution and resolution with few adverse events.
- 4 November 2014
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 108 (6) , 473-480
Open AccessPulsed dye laser therapy for infantile hemangiomas: a systemic review and meta-analysis
Background: Infantile hemangiomas (IH) are common pediatric tumors. This meta-analysis was performed to review the therapeutic efficacy and safety of pulsed dye laser (PDL) in the treatment of IH. Methods: Seven databases were searched, including PubMed, OvidSP, Karger, Elsevier, EMBASE, Web of Science and Wiley Online Library. The review collected the characteristics of year of publication, hemangiomas cases, prior treatment, laser parameters, adverse side, pretreatment symptom, and number of response from all articles. Results: A total of 1580 studies were identified, the first round search retrieved 39 articles met inclusion criteria. Of those, only 13 articles with 1529 hemangiomas were included in the meta-analysis. This meta-analysis demonstrated an overall resolution rate of 89.1% with 6.28% incidence of adverse effect. Conclusion: PDL may be the effective modality to decrease the proliferative phase and accelerate rates of involution and resolution with few adverse events.
- 1 October 2014
- Published by Elsevier in Biomaterials
- Vol. 35 (30) , 8514-8527
Effect of nano-structured bioceramic surface on osteogenic differentiation of adipose derived stem cells
- 1 October 2014
- Published by Elsevier in Biomaterials
- Vol. 35 (30) , 8514-8527
Effect of nano-structured bioceramic surface on osteogenic differentiation of adipose derived stem cells
- 16 October 2013
- Published by Wiley in Clinical Implant Dentistry and Related Research
- Vol. 17 (4) , 798-810
Comprehensive Evaluation of Cryopreserved Bone‐Derived Osteoblasts for the Repair of Segmental Mandibular Defects in Canines
Background: The repair of segmental mandibular defects remains challenging in the clinic. Previous studies have shown that cryopreserved bone‐derived osteoblasts (CBOs) have good proliferation and osteogenicity. However, whether these cells can be used in the repair of segmental mandibular defects is largely unknown.Purpose: In this study, we applied CBOs combined with beta‐tricalcium phosphate (β‐TCP) to repair a segmental mandibular defect in canines and thus established the feasibility of using this type of tissue‐bank cell for the repair of large bone defects in the future.Material and Methods: Sixteen segmental mandibular defects in 16 animals were made on the right side. Sequential radiographs, computer tomography, polychrome fluorescent labeling, immunohistochemical staining, and histological analysis were used to evaluate the effects of tissue‐engineered bone for segmental mandibular defects.Results: Our results demonstrated that CBOs combined with β‐TCP promoted bone mineralization and deposition at the early stage, and bony union was achieved in the CBO and fresh bone‐derived osteoblast (FBO) groups. However, nonunion and minimal callus were present in the β‐TCP group. Furthermore, there was a large amount of newly formed bone in the CBO and FBO groups and in the autogenous bone group. Additionally, osteocalcin immunohistochemistry showed intensive osteocalcin immunoreactivity in the bone matrix of the CBO and FBO groups.Conclusions: These data indicate that CBOs implanted in a scaffold can promote new bone formation, and this tissue‐engineered bone can repair critically sized segmental mandibular defects in canines. The use of CBOs combined with β‐TCP may be an effective approach for the reconstruction of segmental mandibular defects in the clinic.
- 16 October 2013
- Published by Wiley in Clinical Implant Dentistry and Related Research
- Vol. 17 (4) , 798-810
Comprehensive Evaluation of Cryopreserved Bone‐Derived Osteoblasts for the Repair of Segmental Mandibular Defects in Canines
Background: The repair of segmental mandibular defects remains challenging in the clinic. Previous studies have shown that cryopreserved bone‐derived osteoblasts (CBOs) have good proliferation and osteogenicity. However, whether these cells can be used in the repair of segmental mandibular defects is largely unknown.Purpose: In this study, we applied CBOs combined with beta‐tricalcium phosphate (β‐TCP) to repair a segmental mandibular defect in canines and thus established the feasibility of using this type of tissue‐bank cell for the repair of large bone defects in the future.Material and Methods: Sixteen segmental mandibular defects in 16 animals were made on the right side. Sequential radiographs, computer tomography, polychrome fluorescent labeling, immunohistochemical staining, and histological analysis were used to evaluate the effects of tissue‐engineered bone for segmental mandibular defects.Results: Our results demonstrated that CBOs combined with β‐TCP promoted bone mineralization and deposition at the early stage, and bony union was achieved in the CBO and fresh bone‐derived osteoblast (FBO) groups. However, nonunion and minimal callus were present in the β‐TCP group. Furthermore, there was a large amount of newly formed bone in the CBO and FBO groups and in the autogenous bone group. Additionally, osteocalcin immunohistochemistry showed intensive osteocalcin immunoreactivity in the bone matrix of the CBO and FBO groups.Conclusions: These data indicate that CBOs implanted in a scaffold can promote new bone formation, and this tissue‐engineered bone can repair critically sized segmental mandibular defects in canines. The use of CBOs combined with β‐TCP may be an effective approach for the reconstruction of segmental mandibular defects in the clinic.
- 2 August 2013
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 1 (40) , 5403-5416
Enhanced osteogenesis through nano-structured surface design of macroporous hydroxyapatite bioceramic scaffolds via activation of ERK and p38 MAPK signaling pathways
The design of the three-dimensional (3D) porous structures and surface morphological/topographies of implants is considered as a novel approach to enhance the bioactivity and osteoinductive ability in the field of bone regeneration. In the present study, highly interconnective macroporous hydroxyapatite (HAp) bioceramic scaffolds with nanosheet, nanorod and micro-nano-hybrid (the hybrid of nanorod and microrod) surface topographies were fabricated using α-tricalcium phosphate (α-TCP) ceramic scaffolds as precursors, through regulation of the hydrothermal reaction conditions. Moreover, the effects of these three surface topographies on attachment, proliferation and osteogenic differentiation of rat bone marrow stromal cells (bMSCs) as well as the related mechanisms were systematically investigated. The results showed that the HAp bioceramics with these micro-/nano-topography surfaces significantly enhanced cell attachment, cell viability, alkaline phosphatase (ALP) activity, and mRNA expression levels of osteoblast-related genes of bMSCs. In particular, the biomimetic feature of the micro-nano-hybrid topography surface possessed the highest stimulatory effect. The activation in extracellular signal-related kinases (ERK), and p38 mitogen-activated protein kinase (MAPK) signaling pathways was observed in bMSCs cultured on HAp bioceramics with micro-/nano-topography surfaces especially for the micro-nano-hybrid topography surface, and these enhancement effects could be blocked by ERK inhibitor PD98059, and P38 inhibitor SB203580, respectively. Moreover, the in vivo bone regeneration results of rat critical-sized calvarial defect models confirmed that macroporous HAp bioceramics with these micro-/nano-topography surfaces could promote new bone formation and mineralization as compared with the control HAp bioceramic with traditional smooth surfaces, while the scaffold with a micro-nano-hybrid surface could achieve a better effect. The study suggests that the hierarchical micro-nano-hybrid topography shows immense potential in improving the clinical performance of macroporous HAp bioceramics.
- 2 August 2013
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 1 (40) , 5403-5416
Enhanced osteogenesis through nano-structured surface design of macroporous hydroxyapatite bioceramic scaffolds via activation of ERK and p38 MAPK signaling pathways
The design of the three-dimensional (3D) porous structures and surface morphological/topographies of implants is considered as a novel approach to enhance the bioactivity and osteoinductive ability in the field of bone regeneration. In the present study, highly interconnective macroporous hydroxyapatite (HAp) bioceramic scaffolds with nanosheet, nanorod and micro-nano-hybrid (the hybrid of nanorod and microrod) surface topographies were fabricated using α-tricalcium phosphate (α-TCP) ceramic scaffolds as precursors, through regulation of the hydrothermal reaction conditions. Moreover, the effects of these three surface topographies on attachment, proliferation and osteogenic differentiation of rat bone marrow stromal cells (bMSCs) as well as the related mechanisms were systematically investigated. The results showed that the HAp bioceramics with these micro-/nano-topography surfaces significantly enhanced cell attachment, cell viability, alkaline phosphatase (ALP) activity, and mRNA expression levels of osteoblast-related genes of bMSCs. In particular, the biomimetic feature of the micro-nano-hybrid topography surface possessed the highest stimulatory effect. The activation in extracellular signal-related kinases (ERK), and p38 mitogen-activated protein kinase (MAPK) signaling pathways was observed in bMSCs cultured on HAp bioceramics with micro-/nano-topography surfaces especially for the micro-nano-hybrid topography surface, and these enhancement effects could be blocked by ERK inhibitor PD98059, and P38 inhibitor SB203580, respectively. Moreover, the in vivo bone regeneration results of rat critical-sized calvarial defect models confirmed that macroporous HAp bioceramics with these micro-/nano-topography surfaces could promote new bone formation and mineralization as compared with the control HAp bioceramic with traditional smooth surfaces, while the scaffold with a micro-nano-hybrid surface could achieve a better effect. The study suggests that the hierarchical micro-nano-hybrid topography shows immense potential in improving the clinical performance of macroporous HAp bioceramics.
- Open Access
- 10 May 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (5) , e62645
Enhanced Dentin-Like Mineralized Tissue Formation by AdShh-Transfected Human Dental Pulp Cells and Porous Calcium Phosphate Cement
The aim of the present study was to investigate the effect of Sonic hedgehog (Shh) on human dental pulp cells (hDPCs) and the potential of complexes with Shh gene modified hDPCs and porous calcium phosphate cement (CPC) for mineralized tissue formation. hDPCs were cultured and transfected with adenoviral mediated human Shh gene (AdShh). Overexpression of Shh and cell proliferation was tested by real-time PCR analysis, western blotting analysis, and MTT analysis, respectively. The odontoblastic differentiation was assessed by alkaline phosphatase (ALP) activity and real-time PCR analysis on markers of Patched-1 (Ptc-1), Smoothened (Smo), Gli 1, Gli 2, Gli 3, osteocalcin (OCN), dentin matrix protein-1 (DMP-1), and dentin sialophosphoprotein (DSPP). Finally, AdShh-transfected hDPCs were combined with porous CPC and placed subcutaneously in nude mice for 8 and 12 weeks, while AdEGFP-transfected and untransfected hDPCs were treated as control groups. Results indicated that Shh could promote proliferation and odontoblastic differentiation of hDPCs, while Shh/Gli 1 signaling pathway played a key role in this process. Importantly, more mineralized tissue formation was observed in combination with AdShh transfected hDPCs and porous CPC, moreover, the mineralized tissue exhibited dentin-like features such as structures similar to dentin-pulp complex and the positive staining for DSPP protein similar to the tooth tissue. These results suggested that the constructs with AdShh-transfected hDPCs and porous CPC might be a better alternative for dental tissue regeneration.
- 10 May 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (5) , e62645
Open AccessEnhanced Dentin-Like Mineralized Tissue Formation by AdShh-Transfected Human Dental Pulp Cells and Porous Calcium Phosphate Cement
The aim of the present study was to investigate the effect of Sonic hedgehog (Shh) on human dental pulp cells (hDPCs) and the potential of complexes with Shh gene modified hDPCs and porous calcium phosphate cement (CPC) for mineralized tissue formation. hDPCs were cultured and transfected with adenoviral mediated human Shh gene (AdShh). Overexpression of Shh and cell proliferation was tested by real-time PCR analysis, western blotting analysis, and MTT analysis, respectively. The odontoblastic differentiation was assessed by alkaline phosphatase (ALP) activity and real-time PCR analysis on markers of Patched-1 (Ptc-1), Smoothened (Smo), Gli 1, Gli 2, Gli 3, osteocalcin (OCN), dentin matrix protein-1 (DMP-1), and dentin sialophosphoprotein (DSPP). Finally, AdShh-transfected hDPCs were combined with porous CPC and placed subcutaneously in nude mice for 8 and 12 weeks, while AdEGFP-transfected and untransfected hDPCs were treated as control groups. Results indicated that Shh could promote proliferation and odontoblastic differentiation of hDPCs, while Shh/Gli 1 signaling pathway played a key role in this process. Importantly, more mineralized tissue formation was observed in combination with AdShh transfected hDPCs and porous CPC, moreover, the mineralized tissue exhibited dentin-like features such as structures similar to dentin-pulp complex and the positive staining for DSPP protein similar to the tooth tissue. These results suggested that the constructs with AdShh-transfected hDPCs and porous CPC might be a better alternative for dental tissue regeneration.
- 1 May 2013
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 345 (5) , 380-384
Inhibitory Effect of the HPV-16mE6Delta/mE7/TBhsp70Delta Vaccine on Oral Squamous Cell Carcinoma
- 1 May 2013
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 345 (5) , 380-384
Inhibitory Effect of the HPV-16mE6Delta/mE7/TBhsp70Delta Vaccine on Oral Squamous Cell Carcinoma
- Open Access
- 24 January 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (1) , e54645
Trehalose Maintains Bioactivity and Promotes Sustained Release of BMP-2 from Lyophilized CDHA Scaffolds for Enhanced Osteogenesis In Vitro and In Vivo
Calcium phosphate (Ca-P) scaffolds have been widely employed as a supportive matrix and delivery system for bone tissue engineering. Previous studies using osteoinductive growth factors loaded Ca-P scaffolds via passive adsorption often experience issues associated with easy inactivation and uncontrolled release. In present study, a new delivery system was fabricated using bone morphogenetic protein-2 (BMP-2) loaded calcium-deficient hydroxyapatite (CDHA) scaffold by lyophilization with addition of trehalose. The in vitro osteogenesis effects of this formulation were compared with lyophilized BMP-2/CDHA construct without trehalose and absorbed BMP-2/CDHA constructs with or without trehalose. The release characteristics and alkaline phosphatase (ALP) activity analyses showed that addition of trehalose could sufficiently protect BMP-2 bioactivity during lyophilization and achieve sustained BMP-2 release from lyophilized CDHA construct in vitro and in vivo. However, absorbed BMP-2/CDHA constructs with or without trehalose showed similar BMP-2 bioactivity and presented a burst release. Quantitative real-time PCR (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA) demonstrated that lyophilized BMP-2/CDHA construct with trehalose (lyo-tre-BMP-2) promoted osteogenic differentiation of bone marrow stromal cells (bMSCs) significantly and this formulation could preserve over 70% protein bioactivity after 5 weeks storage at 25°C. Micro-computed tomography, histological and fluorescent labeling analyses further demonstrated that lyo-tre-BMP-2 formulation combined with bMSCs led to the most percentage of new bone volume (38.79% ±5.32%) and area (40.71% ±7.14%) as well as the most percentage of fluorochrome stained bone area (alizarin red S: 2.64% ±0.44%, calcein: 6.08% ±1.37%) and mineral apposition rate (4.13±0.62 µm/day) in critical-sized rat cranial defects healing. Biomechanical tests also indicated the maximum stiffness (118.17±15.02 Mpa) and load of fracture (144.67±16.13 N). These results lay a potential framework for future study by using trehalose to preserve growth factor bioactivity and optimize release profile of Ca-P based delivery system for enhanced bone regeneration.
- 24 January 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (1) , e54645
Open AccessTrehalose Maintains Bioactivity and Promotes Sustained Release of BMP-2 from Lyophilized CDHA Scaffolds for Enhanced Osteogenesis In Vitro and In Vivo
Calcium phosphate (Ca-P) scaffolds have been widely employed as a supportive matrix and delivery system for bone tissue engineering. Previous studies using osteoinductive growth factors loaded Ca-P scaffolds via passive adsorption often experience issues associated with easy inactivation and uncontrolled release. In present study, a new delivery system was fabricated using bone morphogenetic protein-2 (BMP-2) loaded calcium-deficient hydroxyapatite (CDHA) scaffold by lyophilization with addition of trehalose. The in vitro osteogenesis effects of this formulation were compared with lyophilized BMP-2/CDHA construct without trehalose and absorbed BMP-2/CDHA constructs with or without trehalose. The release characteristics and alkaline phosphatase (ALP) activity analyses showed that addition of trehalose could sufficiently protect BMP-2 bioactivity during lyophilization and achieve sustained BMP-2 release from lyophilized CDHA construct in vitro and in vivo. However, absorbed BMP-2/CDHA constructs with or without trehalose showed similar BMP-2 bioactivity and presented a burst release. Quantitative real-time PCR (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA) demonstrated that lyophilized BMP-2/CDHA construct with trehalose (lyo-tre-BMP-2) promoted osteogenic differentiation of bone marrow stromal cells (bMSCs) significantly and this formulation could preserve over 70% protein bioactivity after 5 weeks storage at 25°C. Micro-computed tomography, histological and fluorescent labeling analyses further demonstrated that lyo-tre-BMP-2 formulation combined with bMSCs led to the most percentage of new bone volume (38.79% ±5.32%) and area (40.71% ±7.14%) as well as the most percentage of fluorochrome stained bone area (alizarin red S: 2.64% ±0.44%, calcein: 6.08% ±1.37%) and mineral apposition rate (4.13±0.62 µm/day) in critical-sized rat cranial defects healing. Biomechanical tests also indicated the maximum stiffness (118.17±15.02 Mpa) and load of fracture (144.67±16.13 N). These results lay a potential framework for future study by using trehalose to preserve growth factor bioactivity and optimize release profile of Ca-P based delivery system for enhanced bone regeneration.